Displaying 1 - 10 of 11461
Author year
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity. Souza AC, Amaral AC. 2017
Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents. Panthee S, Paudel A, Hamamoto H, Sekimizu K. 2017
Comparative evaluation of Sensititre YeastOne® and CLSI M38-A2 reference method for antifungal susceptibility testing of Aspergillus spp. against echinocandins. Siopi M, Pournaras S, Meletiadis J. 2017
Bibliometric analysis of literature on antifungal triazole resistance: 1980 - 2015. Sweileh WM, Sawalha AF, Al-Jabi S, Zyoud SH. 2017
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Marks DI, Liu Q, Slavin M. 2017
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use. Aversa F, Busca A, Candoni A, Cesaro S, Girmenia C, Luppi M, Nosari AM, Pagano L, Romani L, Rossi G, Venditti A, Novelli A. 2017
Therapeutic Drug Monitoring of Azole Antifungal Medications by Liquid Chromatography-Tandem Mass Spectrometry. McShane A, Wang S. 2017
Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles. Nawrot U, Kurzyk E, Arendrup MC, Mroczynska M, Wlodarczyk K, Sulik-Tyszka B, Wróblewska M, Ussowicz M, Zdziarski P, Niewinska K, Brillowska-Dabrowska A. 2017
FunResDB-A web resource for genotypic susceptibility testing of Aspergillus fumigatus. Weber M, Schaer J, Walther G, Kaerger K, Steinmann J, Rath PM, Spiess B, Buchheidt D, Hamprecht A, Kurzai O. 2017
Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China. Xu XH1, Zhang L2, Cao XX3, Li J4, Zhang W5, Zhu TN6, Cai HC7, Chen M8, Han X9, Yang C10, Han B11, Zhang Y12, Zhuang JL13, Zhou DB14, Duan MH15. 2017


Subscribe to Search